Molecular Imaging
Autor Ralph Weissleder, Brian Ross, Alnawaz Rehemtulla, Sanjiv Sam Gambhiren Limba Engleză Hardback – 16 aug 2010
Preț: 1150.04 lei
Preț vechi: 1210.58 lei
-5%
Puncte Express: 1725
Preț estimativ în valută:
220.33€ • 238.66$ • 188.95£
220.33€ • 238.66$ • 188.95£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781607950059
ISBN-10: 1607950057
Pagini: 1357
Ilustrații: col. Illustrations
Dimensiuni: 225 x 288 x 53 mm
Greutate: 0 kg
Editura: McGraw Hill Education
Colecția McGraw Hill / Europe, Middle East & Africa
Locul publicării:Canada
ISBN-10: 1607950057
Pagini: 1357
Ilustrații: col. Illustrations
Dimensiuni: 225 x 288 x 53 mm
Greutate: 0 kg
Editura: McGraw Hill Education
Colecția McGraw Hill / Europe, Middle East & Africa
Locul publicării:Canada
Cuprins
Part I: Molecular Imaging Technologies1: Imaging of structure and function with PET/CT
2: PET/MRI
3: SPECT and SPECT/CT
4: Principles of micro x-ray computed tomography
5: Small Animal SPECT, SPECT/CT, and SPECT/MRI
6: Instrumentation and methods to combine small animal PET with other imaging modalities
7: Functional Imaging using Bioluminescent Imaging
8: Optical Multimodality
9: Fiber Optic Fluorescence Imaging
10: Fluorescence Tomography
11: Endomicroscopy
12: Intravital Microscopy
13: Diffuse Optical Tomography
14: Ultrasound
15: Molecular Photoacoustic Tomography
16: Optical Projection Tomography
17: Signal Post Processing/Image Reconstruction
Part II: Chemistry of Molecular Imaging
18: Chemistry of Molecular Imaging: an overview
19: Radiochemistry of PET
20: Radiochemistry of SPECT
21: Nanochemistry for Molecular Imaging
22: Newer Bioconjugation Methods
23: Targeted Antibodies and Peptides
24: Hyperpolarized 13C magnetic resonance imaging – Principles and applications
25: MR Imaging Agents
26: Optical Imaging Agents
27: Ultrasound Contrast Agents
28: Multimodality Agents
29: “Click Chemistry”: Applications to Molecular Imaging
30: The “One-Bead-One-Compound” Combinatorial Approach toIdentifying Molecular Imaging Probes
31: Chemical Biology Approaches to Molecular Imaging
32: Theranostics: Agents for diagnosis and therapy
33: Magnetic Nanoparticles
34: Fluorocarbon Agents For Quantitative Multimodal Molecular Imaging and Targeted Therapeutics
35: Aptamers for Molecular Imaging
36: Toxicology
Part III: Molecular Imaging in Cell & Molecular Biology
37: Overview of Molecular and Cell Biology
38: Systems Biology
39: Protein Engineering
40: Phage Display for Agent Development
41: Molecular Imaging of Gene Therapy
42: Developing diagnostic and therapeutic viral vectors
43: Cell Voyeurism using Magnetic Resonance Imaging
44: Tumor vasculature
45: Hypoxia Imaging
46: Protein-Protein Interaction
47: Fluorescence Reporters/Activatable Cell Penetrating Peptides
48: Imaging of Signaling Pathways
Part IV: Applications of Molecular Imaging
49: Molecular and Functional Imaging of the Tumor Microenvironment
50: Novel MR and PET Imaging in the RT Planning and Assessment of Response of Malignant Gliomas
51: PET Diagnosis and Response Monitoring in Oncology
52: MRS Treatment Response and Detection
53: MRI Treatment Response Assessment – Diffusion
54: Myocardial Metabolism
55: Congestive Heart Failure
56: Molecular Imaging of Atherosclerosis
57: Thrombosis and Embolism
58: Molecular Imaging of Stem Cells in Myocardial Infarction
59: Central Nervous System Molecular Imaging
60: Neuroreceptor Imaging
61: Neurodegeneration
62: Molecular Imaging of Autoimmune Diseases
63: Rheumatoid Arthritis
64: Autoimmune Diabetes
65: Imaging in Asthma
Part V: Molecular Imaging in Drug Evaluation
66: Molecular and Functional Imaging in Drug Development
67: PET Imaging Clinical Trials
68: MR Imaging in Clinical Trials
69: Imaging of Gene Therapy: Basis and Clinical Trials
Part VI: Other
70: Visualization
71: Quantification of Radiotracer Uptake into Tissue
72: Mining High Throughput Data for Candidate Biomarkers as Imaging and Therapeutic Targets
73: Pharmacokinetic Modeling
74: Cost-Effectiveness Analysis/Economics of Probe Development
75: Regulatory and Reimbursement Process for Imaging Agents and Devices
2: PET/MRI
3: SPECT and SPECT/CT
4: Principles of micro x-ray computed tomography
5: Small Animal SPECT, SPECT/CT, and SPECT/MRI
6: Instrumentation and methods to combine small animal PET with other imaging modalities
7: Functional Imaging using Bioluminescent Imaging
8: Optical Multimodality
9: Fiber Optic Fluorescence Imaging
10: Fluorescence Tomography
11: Endomicroscopy
12: Intravital Microscopy
13: Diffuse Optical Tomography
14: Ultrasound
15: Molecular Photoacoustic Tomography
16: Optical Projection Tomography
17: Signal Post Processing/Image Reconstruction
Part II: Chemistry of Molecular Imaging
18: Chemistry of Molecular Imaging: an overview
19: Radiochemistry of PET
20: Radiochemistry of SPECT
21: Nanochemistry for Molecular Imaging
22: Newer Bioconjugation Methods
23: Targeted Antibodies and Peptides
24: Hyperpolarized 13C magnetic resonance imaging – Principles and applications
25: MR Imaging Agents
26: Optical Imaging Agents
27: Ultrasound Contrast Agents
28: Multimodality Agents
29: “Click Chemistry”: Applications to Molecular Imaging
30: The “One-Bead-One-Compound” Combinatorial Approach toIdentifying Molecular Imaging Probes
31: Chemical Biology Approaches to Molecular Imaging
32: Theranostics: Agents for diagnosis and therapy
33: Magnetic Nanoparticles
34: Fluorocarbon Agents For Quantitative Multimodal Molecular Imaging and Targeted Therapeutics
35: Aptamers for Molecular Imaging
36: Toxicology
Part III: Molecular Imaging in Cell & Molecular Biology
37: Overview of Molecular and Cell Biology
38: Systems Biology
39: Protein Engineering
40: Phage Display for Agent Development
41: Molecular Imaging of Gene Therapy
42: Developing diagnostic and therapeutic viral vectors
43: Cell Voyeurism using Magnetic Resonance Imaging
44: Tumor vasculature
45: Hypoxia Imaging
46: Protein-Protein Interaction
47: Fluorescence Reporters/Activatable Cell Penetrating Peptides
48: Imaging of Signaling Pathways
Part IV: Applications of Molecular Imaging
49: Molecular and Functional Imaging of the Tumor Microenvironment
50: Novel MR and PET Imaging in the RT Planning and Assessment of Response of Malignant Gliomas
51: PET Diagnosis and Response Monitoring in Oncology
52: MRS Treatment Response and Detection
53: MRI Treatment Response Assessment – Diffusion
54: Myocardial Metabolism
55: Congestive Heart Failure
56: Molecular Imaging of Atherosclerosis
57: Thrombosis and Embolism
58: Molecular Imaging of Stem Cells in Myocardial Infarction
59: Central Nervous System Molecular Imaging
60: Neuroreceptor Imaging
61: Neurodegeneration
62: Molecular Imaging of Autoimmune Diseases
63: Rheumatoid Arthritis
64: Autoimmune Diabetes
65: Imaging in Asthma
Part V: Molecular Imaging in Drug Evaluation
66: Molecular and Functional Imaging in Drug Development
67: PET Imaging Clinical Trials
68: MR Imaging in Clinical Trials
69: Imaging of Gene Therapy: Basis and Clinical Trials
Part VI: Other
70: Visualization
71: Quantification of Radiotracer Uptake into Tissue
72: Mining High Throughput Data for Candidate Biomarkers as Imaging and Therapeutic Targets
73: Pharmacokinetic Modeling
74: Cost-Effectiveness Analysis/Economics of Probe Development
75: Regulatory and Reimbursement Process for Imaging Agents and Devices